Castle Biosciences Insider Sold Shares Worth $574,679, According to a Recent SEC Filing-March 2024-www.financetom.com

Castle Biosciences Insider Sold Shares Worth $574,679, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Castle Biosciences Insider Sold Shares Worth $574,679, According to a Recent SEC Filing

May 8, 2024 2:44 PM

05:22 PM EDT, 05/08/2024 (MT Newswires) -- Daniel Bradbury, Director, on May 06, 2024, sold 23,323 shares in Castle Biosciences ( CSTL ) for $574,679. Following the Form 4 filing with the SEC, Bradbury has control over a total of 14,636 shares of the company, with 4,655 shares held directly and 9,981 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1447362/000144736224000064/xslF345X03/wk-form4_1715201475.xml

Previous page： Kiniksa Pharmaceuticals International Insider Sold Shares Worth $1,962,781, According to a Recent SEC Filing Next page： Hexcel Q3 Adjusted Earnings, Net Sales Fall; 2025 Outlook Changed

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $1,962,781, According to a Recent SEC Filing

Oct 22, 2025

05:14 PM EDT, 10/22/2025 (MT Newswires) -- Michael R Megna, Chief Accounting Officer, on October 20, 2025, sold 50,490 shares in Kiniksa Pharmaceuticals International ( KNSA ) for $1,962,781. Following the Form 4 filing with the SEC, Megna has control over a total of 27,046 Class A ordinary shares of the company, with 27,046 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/xslF345X05/form4-10222025_091045.xml...

Hexcel Q3 Adjusted Earnings, Net Sales Fall; 2025 Outlook Changed

Oct 22, 2025

05:13 PM EDT, 10/22/2025 (MT Newswires) -- Hexcel ( HXL ) reported Q3 adjusted earnings late Wednesday of $0.37 per diluted share, down from $0.47 a year earlier. Analysts polled by FactSet expected $0.36. Net sales for the quarter ended Sep. 30 fell to $456.2 million from $456.5 million a year earlier. Analysts polled by FactSet expected $441.9 million. For...

Blue Ridge Bankshares' Q3 net income rises, boosted by out-of-market loan payoff

Oct 22, 2025

Overview * Blue Ridge Q3 net income rises to $5.6 mln, highest since 2022 * Net interest income for Q3 increases to $21.9 mln * Company announces $15 mln share repurchase program Outlook * Company anticipates lower consulting and legal expenses in the fourth quarter Result Drivers * ONE-TIME EVENTS - Q3 results boosted by $3.0 mln fee income from...

Lam Research expects upbeat quarterly revenue on demand for chipmaking tools

Oct 22, 2025

Oct 22 (Reuters) - Lam Research ( LRCX ) forecast second-quarter revenue above Wall Street estimates on Wednesday, as chipmakers ordered more of its equipment used to manufacture semiconductors for artificial intelligence applications. Shares of the Fremont, California-based company rose 2.2% in trading after the bell. The stock has doubled so far this year, supported by strong demand for AI...